Pharmaceutical . Pharma at Cannes: C’est la Vie . It's not only a venue to gain creative inspiration, but a good place to scout talent, and there are no lack of strategic meetings underway in Cannes.

www.vicorepharma.com This information is information that Vicore Pharma Holding is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for ...

Join us at 1.00pm (BST)/2.00pm (CEST)/8.00am (EDT) on Thursday 10th July for an expert-led discussion exploring the latest ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

Pharmaceutical Resources raised earnings expectations for the third quarter, again, as product sales continue to surpass projections. The maker and distributor of generic pharmaceuticals now ...

Date & Time: 13/06/2025 (17:00 - 18:15 CEST) - Brown Hall 3 MaaT Pharma will also present its ongoing Phase 2b trial (PHOEBUS) design for MaaT033 developed as an adjunctive therapy to enhance ...

Abstract Number: P0069, Abstract Session: Friday, February 21 from 12:40 PM - 1:40 PM CEST (6:40 AM-7:40 AM EST) This study assessed the efficacy and mechanism of action of TP-317 in preclinical ...

NEW YORK (MarketWatch) -- Aspreva Pharmaceuticals, Corp. on Friday said it plans to offer 7.2 million shares at $13-$15 in a bid to raise about $101 million with underwriter Merrill Lynch. The ...

SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations 10-Apr-2025 / 18:15 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of ...

SCHOTT Pharma, a pioneer in pharma drug containment solutions and delivery systems, today reported its results for the first quarter and confirmed all targets for the fiscal year 2025 1. “Our ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland - June 25, 2025Idorsia Ltd. (SIX: IDIA) today announced the positive outcome of two bondholder meetings held at 17:30 CEST and 19:00 ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment ...